Canterbury DHB

Context

Transplant Associated Microangiopathy (TAM)

For a comprehensive review see Obut, F., et al. (2016). "Post-bone marrow transplant thrombotic microangiopathy." Bone Marrow Transplant 51(7): 891-897.

In This Section

Diagnosis

Pathophysiology

Prognosis

Management

Diagnosis

Pathophysiology

Post-transplant TMA is a systemic disease mediated by activation of the alternate complement pathway. It is possibly driven by endothelial damage mediated by:

Prognosis

Management

About this Canterbury DHB document (9094):

Document Owner:

Andrew Butler (see Who's Who)

Issue Date:

December 2016

Next Review:

December 2018

Keywords:

Note: Only the electronic version is controlled. Once printed, this is no longer a controlled document. Disclaimer

Topic Code: 9094